AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Study of Contrast - Induced Nephropathy After Intravenous Contrast Procedures at Sohag University Hospitals

Recruitingn/aAges 18 Years - anyMaleSohag University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Contrast-induced nephropathy (CIN) is a serious complication of angiographic procedures and results from administration of iodinated contrast media (CM). CIN is the third most common cause of hospital acquired acute renal injury representing about 12% of the cases. The reported incidence of CIN varies widely across the literature, depending on the patient population studied and the baseline risk factors . An overall incidence of CIN following intraarterial contrast injection in the general population was reported to be 0.6-2.3%. Although the incidence of CIN is low in patients with normal renal function, its prevalence can be much higher in several patient subsets e.g. diabetics, patients with existing renal insufficiency. Contrast-induced nephropathy is defined as a rise in serum creatinine of at least 0.5 mg/dL or a 25% increase from baseline within 48 to 72 hours after contrast exp

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1- Inpatients and outpatients aged 18years and above who underwent single intravenous Contrast procedures. Exclusion criteria: 1. Patients below 18 years, failure to obtain consent. 2. Patients with ESRD/ on maintenance hemodialysis. 3. New-York Heart Association class IV Congestive Cardiac Failure (CCF) or patients with cardiogenic shock . 4. History of hypersensitivity to contrast in the past or exposure to contrast in the last 24-48 hours, 5-nursing/pregnant subjects. 5. Patients with malignancy or other organ failure like decompensated liver cirrhosis
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

2 sites
Sohag university hospitals
Sohag, Egypt
Sohag university hospitals
Sohag, Egypt
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy